CTL@WCM Special Panel: From Rats to Reagents: Navigating the Untapped Commercial Potential of Academic Research Tools

Research tools, such as cell lines, rodents, and reagents, are an essential part of exploring our unanswered scientific questions. While often overlooked for commercialization, licensing of research tools has the potential to reduce MTA burden and generate sizable financial returns. But what distinguishes an academic project from a successful commercial product?

Join us as we convene a panel of industry experts to learn about the research tools industry and the valuable research tools that might be hiding in your freezer.

Register now

Panelists:

• Karen Wu, Ph.D., President and Co-Founder at Lucerna
• James Hoberg, Ph.D., Head of External Innovation & Licensing, Millipore Sigma
• Chuck Na, MSc, Innovation Manager, ATCC
• Peter Wells, MBA, Contracts & Licensing Manager, The Jackson Laboratory
• Iris Bica, Business Development and Licensing Associate, Weill Cornell Medicine (Moderator)